Aspira Women's Health Inc (AWH) stock has gained 50.17% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With AWH Stock Today?
Aspira Women's Health Inc (AWH) stock has risen 21.52% while the S&P 500 has fallen -1.37% as of 1:08 PM on Wednesday, Jan 27. AWH has risen $1.59 from the previous closing price of $7.39 on volume of 1,453,128 shares. Over the past year the S&P 500 has gained 17.06% while AWH has risen 1066.23%. AWH lost -$0.15 per share in the over the last 12 months.
To see the top 5 stocks in the Diagnostics & Research industry click here.
More About Aspira Women's Health Inc
Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiX testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
Click Here to get the full Stock Score Report on Aspira Women's Health Inc (AWH) Stock.
